Navigation Links
OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
Date:8/2/2009

SEATTLE, Aug. 3 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced results from a study released by Dartmouth-Hitchcock Medical Center at the International Association for the Study of Lung Cancer (IASLC) 13th World Conference on Lung Cancer. The study demonstrated that in patients with advanced non-small cell lung cancer (NSCLC), the combination of OPAXIO (paclitaxel poliglumex) and Alimta(R) (pemetrexed) was well tolerated and resulted in median progression-free survival of 3.3 months.

The study, led by Dr. J. R. Rigas, enrolled twelve patients, six to each of two dose levels. Patients were treated in 21-day cycles, with cohort one receiving 135 mg/m2 of paclitaxel poliglumex and 500 mg/m2 of pemetrexed, and cohort two receiving 175 mg/m2 of paclitaxel poliglumex and 500 mg/m2 of pemetrexed. None of the patients in cohort one had an initial dose-limiting toxicity (IDLT) with two cycles of therapy. There was one IDLT of infection with neutropenia in cohort two. Aside from grade 3 fatigue in two patients, there were no grade 3 or greater nonhematologic toxicities. A median of 4.5 cycles was delivered in each cohort.

The best response was stable disease in nine patients. Two patients remain without evidence of disease progression, and six patients were alive at time of data presentation. Median progression free survival was 3.3 months.

This poster is available at www.celltherapeutics.com/investor_updates

About (product)

OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was formerly known as XYOTAX(TM), is an investigational, biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, the chemotherapy is rendered inactive, potentially sparing normal tissue
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
2. Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer
3. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
4. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
7. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
8. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
9. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
10. Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia
11. IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... named the 2013 Life Science Firm of the Year by ... Vanda was honored at the TCM,s 25 th Annual ... Maryland.  The Tech Awards Celebration recognizes the leaders and innovators ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... 2013 Nephros, Inc. (OTC Bulletin Board: ... that develops and sells high performance liquid purification ultrafilters, ... In addition, the concurrent temporary reduction in exercise price ... 17, 2013. Nephros estimates that it will ... offering.   A portion of the proceeds will be used ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... PORTLAND, Maine , Jan. 18 Putney, Inc., a ... Jean Hoffman , founder and CEO, will present at the ... 2010 in New York, NY . , The ... private companies within the areas of acute care, distribution, healthcare IT, ...
... , ALLEGAN, Mich., Jan. 7 Perrigo Company ... and CEO Joseph C. Papa will present at the 28th ... 10:00 a.m. (PT) at the Westin St. Francis Hotel in ... healthcare supplier that develops, manufactures and distributes OTC and generic ...
Cached Medicine Technology:Putney to Present at the Jefferies 2010 Global Healthcare Services Conference 2
(Date:5/24/2013)... A recent study by research group Harris Interactive found ... suit season. Almost 138 million people are fearful of pulling ... weight issues and a quarter admit they feel pressured to ... that those anxious about their size consider the over the ... overall effort to improve diet and exercise habits ahead of ...
(Date:5/24/2013)... Cheap Concert Tickets announces that Taylor ... can add code RED for added savings. , Taylor ... 1.2 million sales during the first week. Since it was released ... the Billboard Album charts, with sales of more than 2,380,000 copies. ... expected to continue at a fast clip in 2013. , The ...
(Date:5/24/2013)... Part guidebook, part memoir, Peter Amato, M.A., ... true approach to meditation for the recovery community. Entitled ... Step, the book outlines a comprehensive method for recovering ... step in any 12-step recovery programs such as Alcoholics ... ever-growing global health problem affecting the physical and psychological ...
(Date:5/24/2013)... Thailand (PRWEB) May 25, 2013 myMEDholiday.com, ... directory of healthcare providers in five important medical travel ... informative International Patient Guide to ensure a safe ... abroad. This 15-step manual offers tips on cost-savings, ... to plan your itinerary, and a wealth other essential ...
(Date:5/24/2013)... 24, 2013 ShopPharmacyCounter.com PhenObestin 37.5 Summer ... have announced price reductions on their popular PhenObestin 37.5 ... helps clients to lose weight as effortlessly as possible ... by more than 50%. , Bottles have been reduced ... and all orders will receive free shipping. , ...
Breaking Medicine News(10 mins):Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3Health News:Taylor Swift Tickets: Cheap Concert Tickets has Slashed Prices on Taylor Swift Concert Tickets in Arlington/Dallas, Philadelphia, East Rutherford, Los Angeles & Tacoma 2Health News:Taylor Swift Tickets: Cheap Concert Tickets has Slashed Prices on Taylor Swift Concert Tickets in Arlington/Dallas, Philadelphia, East Rutherford, Los Angeles & Tacoma 3Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 2Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 3Health News:myMEDholiday.com Introduces International Patient Guide to Assist People Planning Treatment Abroad 2Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2
... Facial expressions convey strong cues for someone,s emotional ... crucial in social interaction. This ability is known to ... as social anxiety or Korsakoff,s syndrome. New research has ... also characterized by changes in the way the brain ...
... 16 (HealthDay News) -- Many women in the United States ... due to dangerous ingredients, a new study indicates. Pai ... which are banned in the United States because they increase ... U.S. Food and Drug Administration announced a recall of Pai ...
... exercise routine means being able to overcome the obstacles ... the confidence that you can do it, researchers report. ... abilities increase this "situation-specific self-confidence," a quality the researchers ... self-efficacy to every single health behavior you can think ...
... You might want to take a pass on that nightcap, ... hinders the restorative functions of sleep. The findings, from ... in the November print issue of the journal Alcoholism: ... sleep appears linked to a disruption in nervous system function. ...
... , MONDAY, Aug. 15 (HealthDay News) -- ,Just 15 minutes ... by 14 percent and increase your life expectancy by three years, ... do at least 150 minutes, or a total of 1.5 hours, ... that doing even half that -- 15 minutes daily is about ...
... public standards incorporating new tests for impurities as well ... of over-the-counter (OTC) ingredients and products will be key ... co-sponsored by the U.S. Food & Drug Administration (FDA) ... addition to providing updates on new standards for acetaminophen ...
Cached Medicine News:Health News:Reduced recognition of fear and sadness in post-traumatic stress disorder 2Health News:U.S. Women Using Dangerous Weight-Loss Pill 2 Years After Recall 2Health News:Want to keep your exercise resolutions? New research offers pointers 2Health News:Want to keep your exercise resolutions? New research offers pointers 3Health News:More Evidence That Alcohol Hinders Good Sleep 2Health News:A Little Exercise Goes a Long Way to Cut Disease, Death Risk 2Health News:FDA-USP workshop to preview updated OTC standards 2Health News:FDA-USP workshop to preview updated OTC standards 3
... Mixevac® III represents the latest in advanced ... mixes all types of bone cement safely and ... system ensures the blades scrape the bowl whether ... superior mix. , ,The new bowl ...
... Tobramycin is the original Simplex™ ... the addition of 1g of ... formula, surgeons can expect the ... P Bone Cement, while ensuring ...
... Blood Flow Analyzer is a fast, clinically ... diagnosis of low and normal-tension glaucoma., ,The ... fast, clinically proven measurement that improves detection ... the management of glaucoma, and detection of ...
... Insertion/Removal ,The Mackool Cataract Support ... to the lens capsule and enclosed ... of zonular status. Insertion is ... retractors), and removal is accomplished in ...
Medicine Products: